Interestingly, past reports have noted that patients with LS‐associated colorectal cancer present with tumors with greater immune infiltration and activation, along with better overall survival rates than patients with sporadic MMR deficient (dMMR) colorectal cancer. This evidence concerns the gene MRC1 and Leigh syndrome.